Skip to main content
. 2017 Sep 27;7(1):e1377872. doi: 10.1080/2162402X.2017.1377872

Figure 3.

Figure 3.

PBMCs were obtained from each patient before the first vaccination and 2 weeks after each vaccination. Ex vivo IFN-γ ELISPOT assay were performed for all patients. The GPC3 specific spot number indicates the number of GPC3 peptide-specific spot calculated by subtracting the spot number in a well of HIV peptide. The red point indicates the maximum spot number of each patient after vaccinations. The picture is raw data of the maximum spot of each patient.